Richter launches Forsteo biosimilar in EU
admin 21st August 2019 Uncategorised 0Both products are approved in adults for osteoporosis in various indications. More: Richter launches Forsteo biosimilar in EU Source: News
read more
Both products are approved in adults for osteoporosis in various indications. More: Richter launches Forsteo biosimilar in EU Source: News
read moreThe injection was made as the last two decades have witnessed dramatic, unpredicted changes in fertility levels. More: £708,000 granted for fertility research Source: News
read moreThe ‘life-changing’ drug will be reimbursed for certain people with severe congenital haemophilia A. More: NHS to reimburse Hemlibra Source: News
read moreThe drug giant reported that in the primary analysis population the combination did not meet the primary endpoint. More: AZ’ Imfinzi combo fails lung cancer study Source: News
read moreWith a spinoff for its prescription business on the ropes, Perrigo is treading water in its plans to reinvent its flagging business. Could a merger with another struggling drugmaker—à la Pfizer and Mylan—be the cure? More: Could a 'creative deal'
read moreNovartis’ AveXis has already fired its chief scientific officer Brian Kaspar in connection with the Zolgensma data scandal. But now, we have the scientist’s side of the story from a lawyer who previously helped Elon Musk with his Twitter crisis—and he says
read more© 1994 - 2026 B.M. Pharmaceuticals